Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 33Myelodysplastic Syndromes 9Recurrence 7Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Wilms Tumor 1TP53 1Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Blood Stem Cell Transplantation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Malignant Solid Tumor 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hematopoietic System--Cancer 1Graft vs Host Disease 1Extranodal Extension 1Esophageal Squamous Cell Carcinoma 1

Interventions

Sunitinib 14aldesleukin 10Bevacizumab 8pembrolizumab 7Nivolumab 7pazopanib 5Axitinib 5atezolizumab 4Interferon-alpha 4sintilimab 3durvalumab 3Sorafenib 3Everolimus 3Cyclophosphamide 3Chemotherapy, Adjuvant 3toripalimab 2sargramostim 2olaparib 2lenvatinib 2fludarabine phosphate 2camrelizumab 2avelumab 2Neoadjuvant Therapy 2Laparoscopy 2Ipilimumab 2Interferon alpha-2 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Gene Expression Profiling 2Fluorouracil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Renal Cell × Decitabine × Clear all
NCT04049344 2019-08-08

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
25 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡